News of the company's first government contract comes three years after it entered the Chesapeake Innovation Center in Parole, where it has been busy developing bioterrorism products to protect the military and civilians.
"This is terrific news for PharmAthene," said Stacey Jurchison, company spokesman. "It's a very substantial contract for the company. We're very pleased. We've had an excellent partnership with the Department of...
| This story has expired! You can purchase the full text in our news archives. |
If you encounter other problems, please email nlundskow@capitalgazette.com and include your name, username, and any errors or messages that are displayed. The more information you can provide, the better able we will be to assist you.
In order to post or vote on a comment, you must be signed in with a hometownannapolis account.
Take a look at a summary of Commenting Guidelines.
If you encounter other problems, please email nlundskow@capitalgazette.com and include your name, username, and any errors or messages that are displayed. The more information you can provide, the better able we will be to assist you.